What is the Share Price of Jubilant Pharmova Ltd?

Jubilant Pharmova Ltd share price is ₹1,165.50 As on 04 November, 2025|12:24

Home
>
Stocks
>
Jubilant Pharmova Ltd

Jubilant Pharmova Ltd Share Price

Q: What is the Market Cap of Jubilant Pharmova Ltd?

The Market Cap of Jubilant Pharmova Ltd is ₹18,693 As on 04 November, 2025|12:24

Q: What is PE Ratio of Jubilant Pharmova Ltd?

The P/E ratio of Jubilant Pharmova Ltd is 37.6 As on 04 November, 2025|12:24

Q: What is PB Ratio of Jubilant Pharmova Ltd?

The PB ratio of Jubilant Pharmova Ltd is 2.82 As on 04 November, 2025|12:24

₹ 1,165.50 -4.30 (-0.37%)
Updated on 04-11-2025 12:24 PM

Stock Rating

Pros 2

Cons 5

Jubilant Pharmova Ltd Price Performance

Day's Low
₹1,156.10

Day's High
₹1,180

₹ 1,165.50

52-w low
₹802

52-w high
₹1,309.90

1,165.50

Day's open
₹1,161.10
Previous close
₹1,169.80
VWAP
₹1,168.56
Lower price band
₹935.9
Upper price band
₹1,403.70

Today's Market Action

The last traded share price of Jubilant Pharmova Ltd was 1,165.50 down by -0.37% on the NSE. Its last traded stock price on BSE was 1,165.80 down by -0.28%. The total volume of shares on NSE and BSE combined was 132,439 shares. Its total combined turnover was Rs 15.48 crores.

Jubilant Pharmova Ltd Medium and Long Term Market Action

Jubilant Pharmova Ltd hit a 52-week high of 1,309.90 on 07-11-2024 and a 52-week low of 802 on 07-04-2025. The stock price of Jubilant Pharmova Ltd is up by 5% over the last one month. It is down by -8.16% over the last one year. Don't forget to check the full stock price history in the table below.

Jubilant Pharmova Ltd Fundamentals

Market Cap (Cr): 18693
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Jubilant Pharmova Ltd Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Jubilant Pharmova Ltd Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About Jubilant Pharmova Ltd

Data not available.

Jubilant Pharmova Ltd FAQ's

What is Share Price of Jubilant Pharmova Ltd?

What is the Market Cap of Jubilant Pharmova Ltd?

What is PE Ratio of Jubilant Pharmova Ltd?

What is PB Ratio of Jubilant Pharmova Ltd?

What is the CAGR of Jubilant Pharmova Ltd?

How to Buy Jubilant Pharmova Ltd Share?

Can I buy Jubilant Pharmova Ltd from Samco?

How do I buy Jubilant Pharmova Ltd from Samco?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

Great Cash Conversion of Profits
The business has a great cash conversion ratio since it is able to convert a signifant portion of operating earnings of 117.84% into operating cash flow. This implies a great working capital cycle and large cash flows for either funding growth or dividends. This shall positively impact shareholder returns.
Strong Working Capital Cycle
The company has a great working capital cycle of 0 days which results in lower investments in working capital and higher asset turnover. This reduces capital requirement of the business and drives RoE and cash flow generation positively. This is extremely positive for long term shareholders of the business.

Cons

Low Sustainable RoE
The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
Low Interest Coverage
The company has a very low Interest coverage ratio of 3.31 times which implies that a large portion of operating profits are getting attributed to payment of interest to debtholders. This leaves lower earnings and cash flows for equity shareholders which is negative for returns.
Highly Cyclical Industry
The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
Capital Intensive Business
The company operates an extremely capital intensive business with a low Asset turnover ratio of 0.68. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.

Valuation Analysis

Margin of safety
(04/11/2025)

Margin of Safety Index: High

100.00%

100.00% People are bullish about Jubilant Pharmova Ltd

0.00%

0.00 % People are bearish about Jubilant Pharmova Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %